New hope to halt painful eye attacks linked to arthritis
NCT ID NCT07018206
Summary
This study is testing if a daily pill called upadacitinib can reduce the number of painful eye inflammation flare-ups in adults with axial spondyloarthritis (a type of spinal arthritis). It will include about 200 people in North America and Europe who have had at least one eye flare-up in the past year. The main goal is to see if taking the drug for 52 weeks lowers the rate of these eye attacks compared to the year before treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AXIAL SPONDYLARTHRITIS (AXSPA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.